These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

245 related articles for article (PubMed ID: 23249329)

  • 1. Nanomedicine for multimodality treatment of cancer.
    Mi Y; Guo Y; Feng SS
    Nanomedicine (Lond); 2012 Dec; 7(12):1791-4. PubMed ID: 23249329
    [No Abstract]   [Full Text] [Related]  

  • 2. [Cancer nanotherapy].
    Kathmann W
    Dtsch Med Wochenschr; 2012 Mar; 137 Suppl 1():S11-3. PubMed ID: 22438116
    [No Abstract]   [Full Text] [Related]  

  • 3. Nanomedicine and drug delivery.
    Wei C; Wei W; Morris M; Kondo E; Gorbounov M; Tomalia DA
    Med Clin North Am; 2007 Sep; 91(5):863-70. PubMed ID: 17826106
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nanomedicine: the promise and challenges in cancer chemotherapy.
    Naguib YW; Cui Z
    Adv Exp Med Biol; 2014; 811():207-33. PubMed ID: 24683034
    [No Abstract]   [Full Text] [Related]  

  • 5. Nanomedicine in cancer treatment.
    Yih TC; Wei C
    Nanomedicine; 2005 Jun; 1(2):191-2. PubMed ID: 17292078
    [No Abstract]   [Full Text] [Related]  

  • 6. Cancer nanomedicine: from targeted delivery to combination therapy.
    Xu X; Ho W; Zhang X; Bertrand N; Farokhzad O
    Trends Mol Med; 2015 Apr; 21(4):223-32. PubMed ID: 25656384
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Biodegradable, polymeric nanoparticle delivery systems for cancer therapy.
    Pridgen EM; Langer R; Farokhzad OC
    Nanomedicine (Lond); 2007 Oct; 2(5):669-80. PubMed ID: 17976029
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Programmable nanomedicine: synergistic and sequential drug delivery systems.
    Pacardo DB; Ligler FS; Gu Z
    Nanoscale; 2015 Feb; 7(8):3381-91. PubMed ID: 25631684
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nanotheraputics.
    Ravi Kumar MN; Blanco-Prieto MJ; Waterhouse DN
    Cancer Lett; 2013 Jul; 334(2):155-6. PubMed ID: 23523611
    [No Abstract]   [Full Text] [Related]  

  • 10. Surface-active liposomes for targeted cancer therapy.
    Sofou S
    Nanomedicine (Lond); 2007 Oct; 2(5):711-24. PubMed ID: 17976032
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Peptide chemistry encounters nanomedicine: recent applications and upcoming scenarios in cancer.
    Falanga A; Galdiero S
    Future Med Chem; 2018 Aug; 10(16):1877-1880. PubMed ID: 29921135
    [No Abstract]   [Full Text] [Related]  

  • 12. Anticancer drug delivery with nanoparticles.
    Conti M; Tazzari V; Baccini C; Pertici G; Serino LP; De Giorgi U
    In Vivo; 2006; 20(6A):697-701. PubMed ID: 17203748
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nanoscale drug delivery for targeted chemotherapy.
    Xin Y; Huang Q; Tang JQ; Hou XY; Zhang P; Zhang LZ; Jiang G
    Cancer Lett; 2016 Aug; 379(1):24-31. PubMed ID: 27235607
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Advances in refunctionalization of erythrocyte-based nanomedicine for enhancing cancer-targeted drug delivery.
    Sun D; Chen J; Wang Y; Ji H; Peng R; Jin L; Wu W
    Theranostics; 2019; 9(23):6885-6900. PubMed ID: 31660075
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical nanomedicine: a solution to the chemotherapy conundrum in pediatric leukemia therapy.
    Krishnan V; Rajasekaran AK
    Clin Pharmacol Ther; 2014 Feb; 95(2):168-78. PubMed ID: 24013811
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Targeting carbon nanotubes against cancer.
    Fabbro C; Ali-Boucetta H; Da Ros T; Kostarelos K; Bianco A; Prato M
    Chem Commun (Camb); 2012 Apr; 48(33):3911-26. PubMed ID: 22428156
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Targeting cancer with hyaluronic acid-based nanocarriers: recent advances and translational perspectives.
    Cadete A; Alonso MJ
    Nanomedicine (Lond); 2016 Sep; 11(17):2341-57. PubMed ID: 27526874
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A review: Integrin alphavbeta3-targeted molecular imaging and therapy in angiogenesis.
    Lim EH; Danthi N; Bednarski M; Li KC
    Nanomedicine; 2005 Jun; 1(2):110-4. PubMed ID: 17292065
    [No Abstract]   [Full Text] [Related]  

  • 19. Nanomedicine: sizing up targets with nanoparticles.
    Minchin R
    Nat Nanotechnol; 2008 Jan; 3(1):12-3. PubMed ID: 18654442
    [No Abstract]   [Full Text] [Related]  

  • 20. Engineering the nanoparticle-protein interface for cancer therapeutics.
    Saie AA; Ray M; Mahmoudi M; Rotello VM
    Cancer Treat Res; 2015; 166():245-73. PubMed ID: 25895872
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.